General
Onglyza Defendant Requests A Phased Pretrial Schedule
In a response filed in the Eastern District of Kentucky, Onglyza drugmaker AstraZeneca asked Judge Karen Caldwell, presiding over all Onglyza heart failure lawsuits…
FDA Approves J&J's Invokana For Treating Heart Conditions
The U.S. Food and Drug Administration (FDA) approved the SGLT2 class of drug Invokana to reduce the risk of major cardiovascular (CV) events in high-risk Type 2…
Superior Court Approves $2.5 Million Risperdal Verdict
On October 31, 2018, a unanimous three-judge panel in the Pennsylvania Superior Court upheld the $2.5 million Risperdal verdict awarded to an Alabama boy, who…
Inadequate Warning Claims Against Abilify Makers Tossed
In an order issued on October 29, 2018, the 5th Circuit U.S. Court of Appeals upheld the dismissal of a case involving withdrawal symptoms of Abilify use, stating…
Montana State Attorney Sues Opioid Distributors
On Monday, Attorney General Tim Fox filed a lawsuit against McKesson Corp. and Cardinal Health over the opioids crisis in Montana, U.S.
The lawsuit alleges the two…
Opioid Defendants Head Back To Sixth Circuit
Several opioids defendants, following a quiet appellate proceeding, returned to the Sixth Circuit filing a mandamus petition challenging the U.S. District Judge Dan Polster…
